Company Filing History:
4 out of 672 
2 out of 245 
1 out of 15,488 
Years Active: 2001-2013
Title: The Innovative Contributions of Stephen F. Hardy in Biotechnology
Introduction
Stephen F. Hardy is a prominent inventor based in San Francisco, CA. With an impressive portfolio of 8 patents, he has made significant strides in the field of biotechnology, particularly concerning nucleic acid vectors and their applications in medical treatments. His inventive spirit showcases the intersection of science and innovation, paving the way for advancements in health and diagnostics.
Latest Patents
One of Stephen F. Hardy's latest patents involves a nucleic acid vector that comprises a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV. This invention includes: (i) a eukaryotic promoter, (ii) a sequence encoding a HML-2 polypeptide linked to the promoter, (iii) a prokaryotic selectable marker, (iv) a prokaryotic origin of replication, and (v) a eukaryotic transcription terminator. The applications of these vectors are particularly relevant for in vitro expression and in vivo nucleic acid immunization against prostate tumors. Notably, the preferred HML-2 polypeptide, PCAV, is located in chromosome 22 at 20.428 megabases (22q11.2). Furthermore, the recognition of human endogenous retroviruses of the HML-2 family, which are up-regulated in prostate cancer, can serve as a crucial factor in screening, diagnosing, and treating this disease.
Career Highlights
Stephen F. Hardy has garnered experience at leading corporations such as Chiron Corporation and Novartis Vaccines & Diagnostics GmbH. His work at these organizations has permitted him to push the boundaries of medical research and contribute to significant biotechnological innovations.
Collaborations
Throughout his career, Hardy has collaborated with notable professionals in the field, including John M. Polo and Thomas W. Dubensky, Jr. These partnerships have facilitated the development of innovative ideas and strengthened the impact of his work in biotechnology.
Conclusion
Stephen F. Hardy stands out as a key inventor whose work in biotechnology continues to advance medical science, especially in the area of cancer research. His inventions, particularly in nucleic acid vectors, reflect a commitment to enhancing therapeutic options for diseases such as prostate cancer, highlighting the importance of innovation in improving healthcare outcomes.